Gainers
- Alaunos Therapeutics TCRT stock rose 20.9% to $0.06 during Friday's after-market session. The company's market cap stands at $13.2 million.
- Impel Pharmaceuticals IMPL shares rose 11.98% to $0.27. The company's market cap stands at $6.4 million.
- I-MAB IMAB shares increased by 7.19% to $1.49. The company's market cap stands at $123.1 million.
- Genprex GNPX stock rose 6.63% to $0.23. The company's market cap stands at $13.3 million.
- Ikena Oncology IKNA shares rose 6.59% to $2.1. The company's market cap stands at $101.3 million.
- Adaptimmune Therapeutics ADAP stock increased by 6.22% to $0.48. The market value of their outstanding shares is at $108.5 million.
Losers
- Minerva Surgical UTRS stock declined by 13.1% to $2.45 during Friday's after-market session. The company's market cap stands at $21.7 million.
- Procaps Gr PROC stock fell 12.34% to $2.7. The market value of their outstanding shares is at $304.6 million.
- Virpax Pharmaceuticals VRPX shares fell 9.99% to $0.35. The market value of their outstanding shares is at $4.1 million.
- Asensus Surgical ASXC shares declined by 9.68% to $0.28. The market value of their outstanding shares is at $74.0 million.
- Intensity Therapeutics INTS shares fell 8.94% to $7.34. The company's market cap stands at $100.6 million.
- Forte Biosciences FBRX shares declined by 8.11% to $0.69. The company's market cap stands at $25.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
FBRXForte Biosciences Inc
$18.00-6.90%
GNPXGenprex Inc
$0.92852.03%
IKNAIkena Oncology Inc
$1.7915.5%
IMABI-MAB
$0.96644.70%
INTSIntensity Therapeutics Inc
$1.901.06%
PROCProcaps Group SA
$2.697.17%
TCRTAlaunos Therapeutics Inc
$1.90-3.06%
UTRSMinerva Surgical Inc
$0.000002-98.0%
VRPXVirpax Pharmaceuticals Inc
$0.34003.03%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in